肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

2022 德国指南：实体肿瘤和血液恶性肿瘤患者疱疹病毒在激活的管理

2022-01-07 德国血液学和肿瘤学学会 Ann Hematol

实体肿瘤血液恶性肿瘤疱疹病毒再激活

单纯疱疹病毒或水痘带状的临床在激活经常发生在恶性肿瘤患者中，本文总结了未接受异基因造血干细胞移植或其他细胞治疗的实体肿瘤和恶性血液病患者疱疹病毒再激活的管理提供指导建议。

中文标题：

2022 德国指南：实体肿瘤和血液恶性肿瘤患者疱疹病毒在激活的管理

英文标题：

Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

发布机构：

德国血液学和肿瘤学学会

发布日期：

2022-01-07

简要介绍：

单纯疱疹病毒或水痘带状的临床在激活经常发生在恶性肿瘤患者中，本文总结了未接受异基因造血干细胞移植或其他细胞治疗的实体肿瘤和恶性血液病患者疱疹病毒再激活的管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 德国指南：实体肿瘤和血液恶性肿瘤患者疱疹病毒再激活的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=270c91c00231528d, title=2022 德国指南：实体肿瘤和血液恶性肿瘤患者疱疹病毒在激活的管理, enTitle=Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO), guiderFrom=Ann Hematol, authorId=0, author=, summary=单纯疱疹病毒或水痘带状的临床在激活经常发生在恶性肿瘤患者中，本文总结了未接受异基因造血干细胞移植或其他细胞治疗的实体肿瘤和恶性血液病患者疱疹病毒再激活的管理提供指导建议。, cover=https://img.medsci.cn/2022110/1641818695094_1608702.png, journalId=0, articlesId=null, associationId=2283, associationName=德国血液学和肿瘤学学会, associationIntro=德国血液学和肿瘤学学会(DGHO,German Society of Hematology and Oncology), copyright=0, guiderPublishedTime=Fri Jan 07 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">单纯疱疹病毒或水痘带状的临床在激活经常发生在恶性肿瘤患者中，本文总结了未接受异基因造血干细胞移植或其他细胞治疗的实体肿瘤和恶性血液病患者疱疹病毒再激活的管理提供指导建议。</span></p>, tagList=[TagDto(tagId=5424, tagName=实体肿瘤), TagDto(tagId=45472, tagName=血液恶性肿瘤), TagDto(tagId=121186, tagName=疱疹病毒再激活)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=22838, guiderKeyword=疱疹病毒, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3972, appHits=58, showAppHits=0, pcHits=361, showPcHits=3914, likes=0, shares=10, comments=2, approvalStatus=1, publishedTime=Mon Jan 10 20:36:56 CST 2022, publishedTimeString=2022-01-07, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Mon Jan 10 20:38:39 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 21:49:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 德国指南：实体肿瘤和血液恶性肿瘤患者疱疹病毒再激活的管理.pdf)])
2022 德国指南：实体肿瘤和血液恶性肿瘤患者疱疹病毒再激活的管理.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1183070, encodeId=25fc11830e045, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Jan 11 07:30:27 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183051, encodeId=964a11830513f, content=期待领教, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Tue Jan 11 07:16:51 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
    2022-01-11 微探

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1183070, encodeId=25fc11830e045, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Jan 11 07:30:27 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183051, encodeId=964a11830513f, content=期待领教, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Tue Jan 11 07:16:51 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
    2022-01-11 shirly.li19560809

    期待领教

    0